Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Study Evaluating the Value of Vendaje® Compared to the Standard of Care for Non-Healing Diabetic Foot Ulcers
-
Lama AI and Bridge Announce Strategic Partnership to Revolutionize Commercial Lending Distribution
-
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
-
Churchill Substantially Increases Taylor Brook Nickel Project to Capture Newly Interpreted Parallel Magmatic Trend
-
Talicia® Launched in the United Arab Emirates
-
Voyager Space Selected as First Technical Support Team Member for Spaceport Nova Scotia
-
The Township of Union Public Schools Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Tutoring Resources for All Students
-
Wisp Surpasses One Million Patients Served and Rolls Out Ambitious Growth Plan
-
Introducing Skyfire: Payment Rails for AI
-
Onebrief Secures $53M to Build the Future of Military Staffs
-
Tickeron Releases AI Trading Bots based on Price Action for High Volatility Stocks
-
Presenting on the Emerging Growth Conference 74 Day 2 on August 22 Register Now
-
Retension Pharmaceuticals Closes $10.4 Million Oversubscribed Series A to Fund Clinical Trials for Patients Suffering from Resistant and Uncontrolled Hypertension
-
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
-
Limmi adds nationally recognized expert in early disease detection and microbiome biology to Advisory Board
-
Bio-Path Holdings Reports Solid Tumor Patient Response Supporting BP1001-A’s Compelling Potential as Treatment for Advanced Solid Tumors
-
Enterprise to Acquire Piñon Midstream
-
ActiveCampaign Announces Inaugural Product Keynote, Unveils Industry-Defining Innovations
-
CDW to Participate in the Citi 2024 Global TMT Conference
-
D&D Pharmatech Announces Initiation of Dosing in a Phase 2 Trial Designed to Evaluate the Efficacy and Safety of DD01, a Long-Acting, Dual GLP-1/Glucagon Receptor Agonist in Overweight/Obese Subje
-
Western Metallica Announces Successful Renegotiation of Caña Brava Copper Project Option Agreement
-
ADT Appoints Suzanne Yoon to the Company’s Board of Directors
-
OKYO Pharma Announces Chairman Acquires Shares
-
NewGenIvf Announces Filing of 2023 Annual Report with the SEC
-
Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
-
PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy
-
Olema Oncology to Participate in Morgan Stanley 22nd Annual Global Healthcare Conference
-
Pharmazz Inc. and Sun Pharma entered into an agreement under which Sun Pharma will invest up to $15 Million in Pharmazz, Inc.
-
Ranchero Enters Into a Letter of Intent to Sell Mexican Subsidiary, and Related Party Loan
-
PEOPLE and Great Place To Work Announce PEOPLE’s '100 Companies that Care' for 2024
-
Bristol Myers Squibb Receives U.S. Food and Drug Administration sBLA Acceptance for First-Line Treatment of Unresectable Hepatocellular Carcinoma
-
Crozier Bolsters Leadership Team with Appointment of New Partners and Announces New Associates
-
Ryder and Terminal Digitize Yard; Achieve 99% Accuracy with AI Computer-Vision
-
Macy’s, Inc. Reports Second Quarter 2024 Results
-
AECOM to serve as program manager for the Portal rail extension in San Francisco
-
YieldMax™ Launches Option Income Strategy ETF on Taiwan Semiconductor (TSM)
-
MRIMath LLC, a Medical AI Company, Announces FDA 510(k) Clearance for its Cyber Device and AI Solution for Glioblastoma
-
Emerging Travel Group Integrates with Sabre SynXis
-
Ferguson Share Repurchase Program - Weekly Report
-
J.Jill, Inc. to Report Second Quarter Fiscal Year 2024 Results on September 4, 2024
-
CTO Realty Growth Completes Three Property Portfolio Acquisition and Disposition of Jordan Landing
-
Waldencast plc Provides Second Quarter and First Half Fiscal 2024 Earnings Conference Call and Webcast Information
-
Nova Minerals Provides an Update on its Estelle Gold-Antimony Project, in Alaska
-
Reporting of transactions made by members of the Board of Directors or Executive Management or their Closely Associated Persons
-
Form 8.3 - [i3 ENERGY PLC - Opening Disclosure - 20 08 2024] - (CGAML)
-
Crown Crafts to Present at the 15th Annual Midwest IDEAS Investor Conference
-
From the Tax Law Offices of David W. Klasing - Georgia Man Sentenced to Prison for Tax Evasion and Failing to File Returns
-
OKX Wallet Integrates with B3 Mainnet, Empowering the Next Generation of Blockchain Gaming
-
Training Industry Recognizes Simplilearn Among Leading Online Learning Library Companies for 2024
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 20 08 2024] - (CGWL)
